Aster DM Quality Care announced a capacity expansion of 184 beds at its material subsidiary KIMS Health Care Management Limited’s (KHML) facility in Trivandrum, Kerala. The board approved the investment of ₹134.4 crore on August 31, 2026, aiming to complete construction by May 2028.

The expansion addresses space constraints and supports the growth of key specialties at the KIMSHEALTH Hospital. Currently, the facility operates with an existing capacity of approximately 795 beds. In FY26, the hospital utilized roughly 596 beds, reflecting an occupancy rate of about 75%.

Expansion Details

The new block will increase the total operational capacity to approximately 979 beds. The company outlined the specific parameters of the project as follows:

Financing Structure

The ₹134.4 crore investment will be financed through a mix of 70% debt and 30% equity. This capital allocation strategy allows the subsidiary to leverage external funding while maintaining equity participation from the parent group.

What the Numbers Show

The current occupancy rate of 75% indicates that the existing infrastructure is operating below full capacity. Adding 184 beds represents a 23% increase in total bed count (from 795 to 979). This suggests management anticipates significant demand growth in the Trivandrum region to absorb the new capacity within the two-year completion window.

The expansion is part of a broader strategy to enhance patient experience and strengthen healthcare infrastructure in Kerala. The company cited the need to optimize existing facilities and facilitate specialty expansion as primary drivers for the new block construction.

The board of Aster DM Quality Care Limited approved the amalgamation of two step-down subsidiaries, KIMSHEALTH Executive Leisure Private Limited (KEL) and Spiceretreat Hospitality Services Private Limited (SHSPL), on August 29, 2026.

The corporate action aims to simplify the group structure and enhance operational efficiencies. The appointed date for the scheme is April 1, 2026.

Transaction Details

KEL, the transferor company, will merge into SHSPL, the transferee company. Both entities are wholly owned subsidiaries of KIMS Health Care Management Limited.

The amalgamation involves a share exchange rather than cash consideration. Shareholders of KEL will receive 13.4391 fully paid-up equity shares of ₹10 each in SHSPL for every 1,000 fully paid-up equity shares of ₹10 each held in KEL.

The fair value of SHSPL shares is ₹43,400 per share, while KEL shares are valued at ₹583.3 per share. These valuations are based on reports dated June 24, 2026, issued by D&P India Advisory Services LLP and Kroll Advisory Private Limited.

Regulatory and Structural Impact

The transaction is classified as a related party transaction but is exempt under Regulation 23(5)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as it involves wholly owned step-down subsidiaries.

The merger is expected to optimize resource utilization, facilitate efficient cash management, and eliminate duplication of regulatory requirements. It will not result in any change to the shareholding pattern of Aster DM Quality Care Limited.

The scheme remains subject to requisite statutory and regulatory approvals.